2017
DOI: 10.1093/jpids/piw071
|View full text |Cite
|
Sign up to set email alerts
|

Rotavirus in Latin America: Current Situation and Perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 17 publications
0
7
0
Order By: Relevance
“…A recent meta-analysis from Ethiopia and Europe also noted an increasing trend of G2P [4], G9P [8], and/or G12P [8] and other previously uncommon genotypes not fully represented in the monovalent Rotarix vaccine that covers the G1P [8] strain [70,94]. Similarly, a significant proportion of diarrheal episodes were consistently noted in an association with the heterotypic G2P [4] rotavirus genotype in Latin America, Belgium, Botswana, and Australia [87,[95][96][97] and G9P [8] in northern Vietnam [98], despite reports of large-scale vaccination with the Rotarix vaccine. While some authors have attributed changing aspects of genotype distribution to lack of sufficient protections against heterologous and the newly emerging rotavirus strains, creating opportunities for strain selection due to vaccine-induced immunological pressures [87,99], others are of the opinion that natural strain fluctuation or gene reassortment events would be more likely to influence the emergence and the epidemiological fitness of variants in the absence of limited herd immunity [22,100].…”
Section: Discussionmentioning
confidence: 96%
“…A recent meta-analysis from Ethiopia and Europe also noted an increasing trend of G2P [4], G9P [8], and/or G12P [8] and other previously uncommon genotypes not fully represented in the monovalent Rotarix vaccine that covers the G1P [8] strain [70,94]. Similarly, a significant proportion of diarrheal episodes were consistently noted in an association with the heterotypic G2P [4] rotavirus genotype in Latin America, Belgium, Botswana, and Australia [87,[95][96][97] and G9P [8] in northern Vietnam [98], despite reports of large-scale vaccination with the Rotarix vaccine. While some authors have attributed changing aspects of genotype distribution to lack of sufficient protections against heterologous and the newly emerging rotavirus strains, creating opportunities for strain selection due to vaccine-induced immunological pressures [87,99], others are of the opinion that natural strain fluctuation or gene reassortment events would be more likely to influence the emergence and the epidemiological fitness of variants in the absence of limited herd immunity [22,100].…”
Section: Discussionmentioning
confidence: 96%
“…By the end of 2014, more than 70 countries had introduced the rotavirus vaccine into their routine childhood immunization programs [1]. Effectiveness of rotavirus vaccines against hospitalizations and severe diarrhea in Latin American children has been approximately 70%, with notable reductions in mortality rates in Brazil, Mexico, and Panama where the vaccination coverage was >80% [17]. Until recently, Costa Rica and Belize were the only two countries in Central America without universal rotavirus vaccination [18,19].…”
Section: Introductionmentioning
confidence: 99%
“…These findings correspond with the trends observed from other Latin American countries such as Brazil and Panama which were also early in their implementation of a national rotavirus vaccination program. 45,46 In Mexico, G9, a strain fully heterotypic from the vaccine strain, has emerged as an important serotype causing severe rotavirus gastroenteritis. 11,47 We identified one study that showed high vaccine effectiveness (94%) against laboratory-confirmed G9P [4] rotavirus infection, 43 indicating that the strain predominance in Mexico was unrelated to vaccine pressure.…”
Section: Discussionmentioning
confidence: 99%
“…These findings correspond with the trends observed from other Latin American countries such as Brazil and Panama which were also early in their implementation of a national rotavirus vaccination program. 45 , 46 …”
Section: Discussionmentioning
confidence: 99%